Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

Tissue Renewal without Stem Cells

Tissue Renewal without Stem Cells

After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...

Cancer Stem Cells and Tumor Maintenance

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...

Mesenchymal Stem Cells

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Multimodal C9-66 CAR-T cell immunotherapy improves outcome in preclinical models of pancreatic cancer.

Gut·2026

Same author

Targeting TMED4 enhances CD8<sup>+</sup> T cell function and CAR T cell efficacy in solid tumors through the IRE1α-autophagy axis.

Science advances·2026

Same author

NGFR induces melanoma invasion and immunotherapy resistance through myosin light chain 2 modulation.

The EMBO journal·2026

Same author

RHOV couples EMT-associated plasticity to cytoskeletal execution of invasion and metastasis.

Cell death discovery·2026

Same author

GPTBioInsightor-leveraging large language models for transparent scRAN-seq cell type annotations.

Bioinformatics advances·2026

Same author

The interplay between tissue-resident microbiome and host proteins by integrated multi-omics during progression of colorectal adenoma to carcinoma.

iMeta·2025

Search research articles

Related Experiment Video

Updated: May 12, 2026

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

Stem cells & pancreatic cancer.

Susana García-Silva¹, Javier Frias-Aldeguer, Christopher Heeschen

¹Stem Cells & Cancer Group, Clinical Research Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.

Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]

|April 9, 2013

Summary

Pancreatic cancer stem cells (CSCs) drive tumor growth and treatment resistance. Future research should focus on in vivo identification and targeted therapies to improve patient survival.

More Related Videos

Isolation of Stem Cells from Human Pancreatic Cancer Xenografts

Isolation of Stem Cells from Human Pancreatic Cancer Xenografts

Published on: September 26, 2010

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Published on: February 2, 2024

Related Experiment Videos

Last Updated: May 12, 2026

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

Isolation of Stem Cells from Human Pancreatic Cancer Xenografts

Isolation of Stem Cells from Human Pancreatic Cancer Xenografts

Published on: September 26, 2010

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Published on: February 2, 2024

Area of Science:

Oncology
Cancer Stem Cell Biology

Background:

Pancreatic ductal adenocarcinoma (PDAC) harbors cancer stem cells (CSCs) with self-renewal and tumor-forming capabilities.
These pancreatic CSCs exhibit chemotherapy resistance and are linked to tumor relapse and metastasis.

Purpose of the Study:

To advance pancreatic CSC research by identifying and characterizing CSCs in their native in vivo environment.
To explore the influence of the tumor stroma on CSC biology through in vivo imaging.
To integrate the CSC concept with clonal evolution models for pancreatic cancer.

Main Methods:

Utilizing lineage tracing and clonal analysis for in vivo CSC identification, similar to glioblastoma research.
Employing in vivo imaging techniques to observe CSC behavior during tumor development.
Conducting comprehensive studies on tumor heterogeneity and clonal evolution.

Main Results:

Pancreatic CSCs are confirmed to possess self-renewal and tumorigenic potential.
CSCs demonstrate significant chemotherapy resistance, contributing to treatment failure.
The study highlights the need for in vivo characterization of CSCs.

Conclusions:

Identifying and characterizing pancreatic CSCs in vivo is crucial for understanding tumor development and heterogeneity.
Targeted therapies against pancreatic CSCs and their supportive stroma offer a promising strategy to improve patient outcomes.
Integrating CSC research with clonal evolution models may unify current understanding of pancreatic cancer progression.